Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial).

Roland Lang; P Koelblinger; E Richtig; I Wolf; C Hoeller; C Hafner; VA Nguyen; J Kofler; M Barta; Wolfgang Hitzl; Martin Laimer

Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial).

Roland Lang, P Koelblinger, E Richtig, I Wolf, C Hoeller, C Hafner, VA Nguyen, J Kofler, M Barta, Wolfgang Hitzl, Martin Laimer

Research output: Contribution to journal › published Abstract (Journal) › peer-review

2 Citations (Web of Science)

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	40
Issue number	16
Publication status	Published - 2022

Cite this

Lang, R., Koelblinger, P., Richtig, E., Wolf, I., Hoeller, C., Hafner, C., Nguyen, VA., Kofler, J., Barta, M., Hitzl, W., & Laimer, M. (2022). Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial). JOURNAL OF CLINICAL ONCOLOGY , 40(16).

Lang, Roland ; Koelblinger, P ; Richtig, E et al. / Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial). In: JOURNAL OF CLINICAL ONCOLOGY 2022 ; Vol. 40, No. 16.

@article{17730c72b40a4d6aa1f454b60d799a80,

title = "Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial).",

author = "Roland Lang and P Koelblinger and E Richtig and I Wolf and C Hoeller and C Hafner and VA Nguyen and J Kofler and M Barta and Wolfgang Hitzl and Martin Laimer",

year = "2022",

language = "English",

volume = "40",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "16",

}

Lang, R, Koelblinger, P, Richtig, E, Wolf, I, Hoeller, C, Hafner, C, Nguyen, VA, Kofler, J, Barta, M, Hitzl, W & Laimer, M 2022, 'Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial).', JOURNAL OF CLINICAL ONCOLOGY , vol. 40, no. 16.

Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial). / Lang, Roland; Koelblinger, P; Richtig, E et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 40, No. 16, 2022.

Research output: Contribution to journal › published Abstract (Journal) › peer-review

TY - JOUR

T1 - Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial).

AU - Lang, Roland

AU - Koelblinger, P

AU - Richtig, E

AU - Wolf, I

AU - Hoeller, C

AU - Hafner, C

AU - Nguyen, VA

AU - Kofler, J

AU - Barta, M

AU - Hitzl, Wolfgang

AU - Laimer, Martin

PY - 2022

Y1 - 2022

M3 - published Abstract (Journal)

SN - 0732-183X

VL - 40

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 16

ER -

Lang R, Koelblinger P, Richtig E, Wolf I, Hoeller C, Hafner C et al. Efficacy and safety of nivolumab for locally advanced or metastatic cutaneous cell carcinoma (NIVOSQUACS trial). JOURNAL OF CLINICAL ONCOLOGY . 2022;40(16).